NCOH Partners are involved in a recently-granted One Health European Joint Programme, which started last January. In the One Health EJP, 39 partners from 19 EU member states are gathered to create a sustainable European One Health framework by integration and alignment of medical, veterinary and food institutes through joint programming of research agendas matching the needs of European and national policy makers and stakeholders. In the Netherlands, these organisations are already collaborating closely to counteract the threat of emerging zoonoses and antimicrobial resistance. The Dutch One Health approach can now also be deployed at EU level. The One Health EJP will run for five years with a total budget of 90 Million Euro.
The NCOH Partners WBVR (WUR) and RIVM are beneficiaries within the One Health EJP. Connected to these beneficiaries as third parties are the NCOH Partners Erasmus MC, UMC Utrecht, Utrecht University/Faculty of Veterinary Medicine and Wageningen University. They participate in the following projects:
|Project||Theme||Lead institute||Project lead||NCOH partners
|Impart||AMR||WBVR||Kees Veldman||WBVR, UU/FD||JRP1|
|RADAR||AMR||RIVM||Eelco Franz||RIVM, WBVR, UMCU||JRP3|
|METASTAVA||Food Borne Zoonoses||SCIENSANO||Steven van Borm||EMC||JRP8|
|MOMIR PPC||Food Borne Zoonoses||INRA||Philipe Velge||WBVR, WU||JRP10|
|METVETKLEBS||Food Borne Zoonoses||IP||Sylvian Brisse||UMCU||JRP11|
These projects are part of the first internal project round.
The call for the second round will be launched in the second half of 2018. NCOH Partners can participate in this call as third parties linked to either RIVM or WBVR. More information will follow via Hendrik-Jan Roest, NCOH and WBVR representative in the One Health EJP.
More information can be found on the following websites:
Young NCOH is the network for PhD students and post-docs from the NCOH research groups. Aim of the network is sharing knowledge and expertise in One Health related disciplines, which can lead to new collaborations in research. The kick off of the network takes place at the Annual Scientific Meeting, 17 May 2019 (ASM2019).
Rory de Vries (born 1982) is receiving the premium for his research on the human body’s defences against respiratory viral infections, and for his ability to communicate his knowledge of virology and infectious diseases to a wide audience. Rory de Vries is a post-doctoral researcher at Erasmus MC in Rotterdam.
On Thursday, 28 February 2019, the ‘One Health’ debate will take place in The Hague. This debate is the conclusion of the Castellum research programme: a public-private partnership aimed at developing vaccines against zoonoses.
Contamination with resistant bacteria in patients admitted to Dutch hospitals does not result in higher mortality than contamination by non-resistant bacteria. Although the problem of antibiotic resistance in the Netherlands currently seems manageable, it is important to remain vigilant in view of the ever-changing epidemiology of resistant bacteria, according to Wouter Rottier, who was awarded...